Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26